FDA Investigator Anna L Marroquin
Anna L Marroquin has inspections in 1 countries as of 12 Apr 2024. Anna L Marroquin has collaborated with a combined 1793 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
61
Last Inspection Date:
12 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alex G Kalugin,
Angel K Sandhu,
Anna L Viveros Hernandez,
Annie H Lam,
Ashar P Parikh,
Carr,
Carr Sharpe,
Carrie E Thrasher,
Chloe Anne K Le,
Chloe Anne Leong,
Christine M Parmentier,
Christopher J Lee,
Courtney R Bolton,
Daniel C Geffin,
Daniel J Roberts,
Daniel Velasquez,
Davis,
Deborah K Richardson,
Dena L Jacobs,
Elva M Ibarra,
Emal Wahab,
Eric W Anderson,
Erica L Nicoll,
Erica R Pomeroy,
Estefania Fernandez,
Esther A Ofori,
Frank P Bianco,
Gillenwater,
Grace P Santos,
Greg K Keshishyan,
Gulshan R Anand,
Helen J Hamaoka,
Herbert E Arden,
Humberto Z Gomez,
Ingrid A Zambrana,
Ismael Garibay,
Jacqueline O Snell,
James A Barreto,
James C Lee, PharmD,
James C Yee,
Janice R Small,
Jazmine M Welcher,
Jennifer Crumb,
Jennifer S King,
Jessica M Wooten,
Joan T Briones,
Joanne M Fukuda,
John Cheung,
Jonathan M Mcbride,
Jorge L Bertran,
Joseph M Willems,
Joseph Tibay,
Jude C Dikes,
Judy C Nepsa,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karen M Willis,
Karla J Gibler,
Kawshalya Pathiraja,
Kevin Lee,
Kevin T Gerrity,
Kimberly L Anderson,
Kimberly L Pruszko,
Kristen E Szenderski,
Lee,
Leongc,
Ligia M Sanders,
Lija V Fellows,
Lisa H Nakagawa,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lucila B Nwatu,
Macropolk,
Maridali De Leon Torres,
Mark E Baldwin,
Mary C Wall,
Mary R Hole,
Matthew A Walburger,
Mcgrewp,
Michael D Garcia,
Michelle L Tripp,
Ngoc B Kelsch,
Nympha V Florendo,
Patricia F Alberico,
Patrick E Gainer,
Peter E Baker,
Phung,
Randall F Albright,
Randall J Plunkett,
Raymond Souweha,
Rebecca E Sulpacio,
Robles,
Rocio Guzman Velazquez,
Ronald P Boyce,
Rumany C Penn, PharmD,
Sean P Desbrow,
Seyyida Saterfield,
State Agency,
Steve P Yost,
Steven J Branch,
Thomas W Gordon,
Tomanik'e C Banks,
Victoria L Morgan,
Wen Jun Peng,
William J Foust,
William J Weis,
Yen Tso Kuo
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more